MEGAPHARMA
Last board
1 director, 1 auditor, last change in 2021Director, permanent representative Gilles Jourquin
since 14-07-2021
6-year term from 2021
also on the board of 2 other companies
listed in the 2022 annual accounts, filed on 01-03-2023
Commissaire pour les comptes statutaires, permanent representative ANTONELLO Cédric
appointed by deed of 22-07-2020
Permanent representatives 1
Gilles Jourquin
Permanent representative, for GJ LIFESCIENCES MANAGEMENT
appointed by deed of 28-09-2021
Mandates through the years
3 names, the dashed line is todayGJ LIFESCIENCES MANAGEMENT
Director
Director
BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISES
Commissaire pour les comptes statutaires
Commissaire pour les comptes statutaires
JGO
Manager
Manager
BoardEarlierRest of the termmandate already running before its first mention
Mandates as a list
- GJ LIFESCIENCES MANAGEMENT
- Director, from 14-07-2021 to date
- BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISES
- Commissaire pour les comptes statutaires, appointed by deed of 22-07-2020, still in office
- JGO
- Manager, until 28-09-2021
Control
Consolidating parent
Equity €86.3m
Profit €138,686 in 2026 (loss €42,260 in 2025)
Checked score 86
consolidates
This company
MEGAPHARMA
Equity €13,166
Loss €3,726 in 2022
Capital
- Contribution
- €20,000
- Shares
- 1,000 in the 2021 annual accounts
- Contribution per share
- €20
- Equity per share
- €13.17 in 2022
- Source
- 2022 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- NEWPHARMA GROUP
- SMARTVALUE
- SKYCO
Source: parent in its own accounts, lists of holdings in the owners' accounts